CV Sciences Enters Distribution Agreement with GNC

+PlusCBD brand products will be available in 770 GNC locations.

Image courtesy of CV Sciences.

San Diego, CA—Beginning in early 2022, consumers will be able to purchase CV Sciences’ +PlusCBD brand in 770 GNC locations, according to a press release.

The initial product assortment will include the following items:

  • Extra Strength Formula; Cherry Mango Gummies – 10mg CBD per gummy, 30 count
  • Extra Strength Formula; Softgels – 15mg per serving, 30 count
  • Extra Strength; Peppermint Liquid – 10mg per serving
  • Raspberry Sleep Gummies – 10mg per gummy with Magnolia, Lemon Balm & Melatonin, 30 count
  • Strawberry Lemonade Calm Gummies – 10mg per gummy with L-Theanine & 5-HTP, 30 count

Related: CV Sciences Developing CBD-based Pharma for Nicotine Addiction
Elixinol Enters Partnership for Distribution in U.K.
“The era of CBD prohibition in California is over” as Newsom Signs Bill

“We are thrilled to partner with GNC, a leading global health and wellness brand, and view this agreement as a major milestone in our distribution expansion strategy as well as a strong testament to the safety and efficacy of CV Sciences’ portfolio of high-quality products,” said Joseph Dowling, Chief Executive Officer of CV Sciences. “This agreement is also a positive reflection of the favorable regulatory momentum that is starting to build following the recent passage of AB 45 in California, which should serve as a framework for responsible CBD legislation in other states and eventually at the federal level.”